Cardiovascular
This category includes articles surrounding cardiovascular and metabolic diseases, including CVD, new innovations and treatment options.
Pharmafile speaks to Scott Curley about CVD, the impact COVID-19 had on the pharma industry specifically in relation to CVD and the next steps for cardiovascular treatment in the UK
Stefan Woxström at AstraZeneca considers the high rates of non-communicable diseases and how governments and healthcare systems can improve their treatments
The challenge of cardiovascular disease: Daiichi Sankyo tells Pharmafile about their role in improving access to cardiovascular treatments and the prevention of CVD
Patients can benefit from new RNA-based therapeutics for metabolic care
What treatments can be used for diuretic-resistant congestion in chronic heart failure, and what challenges face them?
Pharmafile
Therapeutic areas in focus